J-SUPPORT 2201
J-SUPPORT 2201
Study Title | Feasibility randomized, placebo-controlled trial of efficacy of midazolam as the second-line treatment for dyspnea in patients with advanced cancer |
---|---|
Principal Investigator/Study Manager/Mentor | Masanori Mori /Satoru Miwa /Hiroshi Ishiguro |
Condition | |
UMIN Clinical Trials Registry | |
Funding Source | |
Protocol Paper | |
Publication | |
Spreading effect |
|